Ellen van der Spek

1.1k total citations
28 papers, 209 citations indexed

About

Ellen van der Spek is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Ellen van der Spek has authored 28 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in Ellen van der Spek's work include Multiple Myeloma Research and Treatments (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ellen van der Spek is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ellen van der Spek collaborates with scholars based in Netherlands, United States and United Kingdom. Ellen van der Spek's co-authors include Niels W.C.J. van de Donk, Andries C. Bloem, Henk M. Lokhorst, A C Bloem, S.P. Beerens, H M Lokhorst, Harm Sinnige, Tuna Mutis, Monique C. Minnema and Richard W.J. Groen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Kidney International.

In The Last Decade

Ellen van der Spek

23 papers receiving 204 citations

Peers

Countries citing papers authored by Ellen van der Spek

Since Specialization

Citations

This map shows the geographic impact of Ellen van der Spek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen van der Spek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen van der Spek more than expected).

Fields of papers citing papers by Ellen van der Spek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen van der Spek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen van der Spek. The network helps show where Ellen van der Spek may publish in the future.

Co-authorship network of co-authors of Ellen van der Spek

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen van der Spek. A scholar is included among the top collaborators of Ellen van der Spek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen van der Spek. Ellen van der Spek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutational profile dynamics in follicular lymphoma and large cell transformation 2025 ·Journal of Clinical Pathology ·(unknown), Wendy B.C. Stevens, Peter Stewart, Leonie I. Kroeze, Ellen van der Spek, Djamila E. Issa, Peet Nooijen, (unknown), David González, Patricia J.T.A. Groenen, Nicole M. A. Blijlevens, Annemiek B. van Spriel, Michiel van den Brand	1
2	Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes 2024 ·HemaSphere ·(unknown), (unknown), Kazem Nasserinejad, Mark‐David Levin, Josien C. Regelink, (unknown), (unknown), Matthijs Westerman, Gerjo A. Velders, Koen de Heer, (unknown), Roel J.W. van Kampen, Claudia A.M. Stege, (unknown), Inger S. Nijhof, Ellen van der Spek, Saskia K. Klein, Niels W.C.J. van de Donk, Paula F. Ypma, Sonja Zweegman	5
3	Hematologists/Physicians Need to Be Aware of Pseudohypercalcemia in Monoclonal Gammopathy: Lessons from a Case Report 2024 ·SHILAP Revista de lepidopterología ·(unknown), Ellen van der Spek, Janneke Ruinemans‐Koerts, Marcel M. G. J. van Borren	0
4	Long-Term Follow-up from the Phase 2 ICON Study of Iberdomide Combined with Low-Dose Cyclophosphamide and Dexamethasone in Relapsed/Refractory Multiple Myeloma (IberCd) 2024 ·Blood ·(unknown), Wouter J. Plattel, Elizabeth de Kort, Alexandra Croockewit, Mark‐David Levin, Matthijs Westerman, Okke de Weerdt, Inger S. Nijhof, Jurgen Wegman, Nico P.M. Smit, Christie P.M. Verkleij, Tuna Mutis, Marjolein van der Klift, (unknown), (unknown), Ellen van der Spek, Wilfried Roeloffzen, Sonja Zweegman, Niels W.C.J. van de Donk	1
5	Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population 2023 ·Histopathology ·(unknown), (unknown), (unknown), Annemiek B. van Spriel, Blanca Scheijen, Jan Willem Leeuwis, Henri A. M. Marres, Patricia J.T.A. Groenen, Wendy B.C. Stevens, Ellen van der Spek, Adriaan J. C. van den Brule, Brigiet M. Hoevenaars, Konnie M. Hebeda, Michiel van den Brand	4
6	Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma 2023 ·HemaSphere ·(unknown), (unknown), (unknown), (unknown), Jos Rijntjes, Annemiek B. van Spriel, Ellen van der Spek, Hans Pruijt, Leonie I. Kroeze, Konnie M. Hebeda, Sandra Croockewit, Wendy B.C. Stevens, J. Han van Krieken, Patricia J.T.A. Groenen, Michiel van den Brand, Blanca Scheijen	4
7	Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study 2021 ·Blood Cancer Journal ·Mirian Brink, (unknown), Pieter Sonneveld, Monique C. Minnema, Annemiek Broijl, Avinash G. Dinmohamed, Ellen van der Spek, Mark‐David Levin, Paula F. Ypma, (unknown), Eduardus F. M. Posthuma, Sonja Zweegman, Niels W.C.J. van de Donk	7
8	Improved design and manufacturing of low frequency broadband underwater transducers 2019 ·TNO Repository ·(unknown), S.P. Beerens, Ellen van der Spek, Rudolf Sprik	1
9	Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial 2017 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Sonja Zweegman, Pieter Sonneveld, Bronno van der Holt, Anders Waage, Saskia K. Klein, Niels Abildgaard, (unknown), Markus Hansson, Fredrik Schjesvold, Mark‐David Levin, Claudia A.M. Stege, (unknown), (unknown), Annemiek Broyl, (unknown), (unknown), Ellen van der Spek, (unknown), Sónia M. P. R. M. Cunha, Einar Haukås	0
10	The Case \| A patient with antineutrophil cytoplasmic antibody–positive vasculitis on treatment with fever and leucopenia 2017 ·Kidney International ·(unknown), Jacobien C. Verhave, Mark A. A. Claassen, Janneke Ruinemans‐Koerts, Ellen van der Spek	3
11	[Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure]. 2015 ·PubMed ·(unknown), Ellen G. van Lochem, Claudia C. Folman, Ellen van der Spek, (unknown)	2
12	Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study) 2013 ·Blood ·Inger S. Nijhof, Sonja Zweegman, Mark‐David Levin, Harry R. Koene, Aart Beeker, Andries C. Bloem, Gerard M.J. Bos, Laura M. Faber, Saskia K. Klein, (unknown), Ellen van der Spek, Shulamiet Wittebol, Jeroen F. van Velzen, Berris van Kessel, Tuna Mutis, Pieter Sonneveld, Henk M. Lokhorst, Niels W.C.J. van de Donk	1
13	Effects of honeybees, Apis mellifera, on insects in nature reserves. 2012 ·Entomologische berichten ·Ellen van der Spek, J. Noordijk, Theo Peeters	1
14	Anti-submarine warfare with continuously active sonar 2011 ·(unknown), S.P. Beerens, Ellen van der Spek	23
15	A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect 2008 ·Haematologica ·Henk Rozemuller, Ellen van der Spek, (unknown), (unknown), Viviènne Verweij, Maarten E. Emmelot, Richard W.J. Groen, Robbert M. Spaapen, A C Bloem, H M Lokhorst, Tuna Mutis, Anton C. Martens	35
16	Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma 2008 ·Leukemia Research ·Ellen van der Spek, Andries C. Bloem, Henk M. Lokhorst, Berris van Kessel, (unknown), Niels W.C.J. van de Donk	20
17	Lenalidomide synergizes with simvastatin in myeloma 2007 ·Haematologica ·Ellen van der Spek, A C Bloem, (unknown), Berris van Kessel, (unknown), H M Lokhorst	0
18	High dose Simvastatin does not reverse resistance to Vincristine, Adriamycin, and Dexamethasone (VAD) in Myeloma 2007 ·Haematologica ·Ellen van der Spek, A C Bloem, Harm Sinnige, H M Lokhorst	24
19	New Treatment Strategies for Multiple Myeloma by Targeting BCL-2 and the Mevalonate Pathway 2005 ·Current Pharmaceutical Design ·Niels W.C.J. van de Donk, Andries C. Bloem, Ellen van der Spek, Henk M. Lokhorst	24
20	Aantasting in droge en natte duinen: dezelfde oorzaken, verschillende gevolgen? 2004 ·UvA-DARE (University of Amsterdam) ·A.M. Kooijman, Albert Grootjans, M. van Til, Ellen van der Spek	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact